Latest Insider Transactions at Insmed Inc (INSM)
This section provides a real-time view of insider transactions for Insmed Inc (INSM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INSMED Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INSMED Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 13
2024
|
William Lewis Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
42,707
+9.51%
|
-
|
|
May 13
2024
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,308
+10.35%
|
-
|
|
May 13
2024
|
Clarissa Desjardins Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,162
+17.52%
|
-
|
|
May 13
2024
|
Leo Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,162
+9.55%
|
-
|
|
May 13
2024
|
David W J Mcgirr Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,162
+11.74%
|
-
|
|
May 13
2024
|
Carol Schafer Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,162
+18.43%
|
-
|
|
May 13
2024
|
Melvin Md Sharoky Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,162
+4.1%
|
-
|
|
May 13
2024
|
David R Brennan Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,162
+9.75%
|
-
|
|
May 13
2024
|
Alfred Altomari Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,162
+15.92%
|
-
|
|
May 13
2024
|
Elizabeth M Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,162
+16.08%
|
-
|
|
Feb 28
2024
|
Melvin Md Sharoky Director |
BUY
Bona fide gift
|
Indirect |
3,600
+23.6%
|
-
|
|
Feb 28
2024
|
Melvin Md Sharoky Director |
SELL
Bona fide gift
|
Direct |
3,600
-1.21%
|
-
|
|
Feb 28
2024
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
50,000
+49.75%
|
$600,000
$12.58 P/Share
|
|
Jan 12
2024
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,251
-3.41%
|
$147,028
$28.63 P/Share
|
|
Jan 12
2024
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,667
-4.18%
|
$130,676
$28.63 P/Share
|
|
Jan 10
2024
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,536
-2.25%
|
$99,008
$28.9 P/Share
|
|
Jan 10
2024
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,245
-1.1%
|
$34,860
$28.9 P/Share
|
|
Jan 09
2024
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
3,668
-1.74%
|
$106,372
$29.15 P/Share
|
|
Jan 09
2024
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
503
+0.47%
|
$10,060
$20.49 P/Share
|
|
Jan 09
2024
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,373
-2.67%
|
$66,444
$28.76 P/Share
|
|
Jan 09
2024
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,861
-1.61%
|
$52,108
$28.78 P/Share
|
|
Jan 09
2024
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,837
-2.38%
|
$111,273
$29.25 P/Share
|
|
Jan 09
2024
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,497
-3.79%
|
$130,413
$29.18 P/Share
|
|
Jan 09
2024
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,715
-4.01%
|
$136,735
$29.01 P/Share
|
|
Jan 09
2024
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
9,887
-2.65%
|
$276,836
$28.72 P/Share
|
|
Jan 08
2024
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
45,120
-5.69%
|
$1,308,480
$29.5 P/Share
|
|
Jan 08
2024
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
45,120
+5.38%
|
$902,400
$20.49 P/Share
|
|
Jan 05
2024
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
6,979
-1.83%
|
$202,391
$29.26 P/Share
|
|
Jan 05
2024
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,457
-1.37%
|
$42,253
$29.28 P/Share
|
|
Jan 05
2024
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
627
-0.7%
|
$18,183
$29.3 P/Share
|
|
Jan 05
2024
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,167
-1.0%
|
$33,843
$29.32 P/Share
|
|
Jan 05
2024
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,042
-1.85%
|
$88,218
$29.21 P/Share
|
|
Jan 05
2024
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,386
-1.17%
|
$40,194
$29.2 P/Share
|
|
Jan 04
2024
|
William Lewis Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
37,869
+9.05%
|
-
|
|
Jan 04
2024
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,800
+9.97%
|
-
|
|
Jan 04
2024
|
Michael Alexander Smith Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,800
+11.66%
|
-
|
|
Jan 04
2024
|
John Drayton Wise Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,873
+9.92%
|
-
|
|
Jan 04
2024
|
Roger Adsett Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,873
+7.27%
|
-
|
|
Jan 04
2024
|
Sara Bonstein Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,873
+9.8%
|
-
|
|
Jan 04
2024
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,873
+9.77%
|
-
|
|
Jan 03
2024
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
20,071
-16.18%
|
$582,059
$29.19 P/Share
|
|
Jan 03
2024
|
John Drayton Wise Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,071
+13.93%
|
$381,349
$19.11 P/Share
|
|
Dec 28
2023
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
22,288
-19.08%
|
$713,216
$32.0 P/Share
|
|
Dec 28
2023
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,288
+16.02%
|
$445,760
$20.49 P/Share
|
|
Dec 22
2023
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
28,310
-21.07%
|
$849,300
$30.0 P/Share
|
|
Dec 22
2023
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
28,310
+17.4%
|
$651,130
$23.66 P/Share
|
|
Dec 22
2023
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,199
-11.14%
|
$395,970
$30.0 P/Share
|
|
Oct 27
2023
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
112,000
-53.31%
|
$2,800,000
$25.04 P/Share
|
|
Oct 27
2023
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
112,500
+30.97%
|
$1,575,000
$14.24 P/Share
|
|
Jul 11
2023
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
740
-0.95%
|
$14,800
$20.18 P/Share
|